vs
Hippo Holdings Inc.（HIPO）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Hippo Holdings Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$120.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 18.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $9.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 18.9%）
河马谷庄园是一座甘蔗种植园，坐落于津巴布韦东南部奇雷济区奇雷济镇附近，位于伦迪河沿岸，毗邻莫桑比克边境，是当地重要的蔗糖产业园区。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HIPO vs PBYI — 直观对比
营收规模更大
HIPO
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出9.6%
18.2%
自由现金流更多
PBYI
多$5.3M
$9.1M
两年增速更快
PBYI
近两年复合增速
18.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.4M | $75.5M |
| 净利润 | $6.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 5.6% | 22.7% |
| 净利率 | 5.0% | — |
| 营收同比 | 18.2% | 27.7% |
| 净利润同比 | -86.4% | — |
| 每股收益（稀释后） | $0.31 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HIPOPBYI
| Q4 25 | $120.4M | $75.5M | ||
| Q3 25 | $120.6M | $54.5M | ||
| Q2 25 | $117.3M | $52.4M | ||
| Q1 25 | $110.3M | $46.0M | ||
| Q4 24 | $101.9M | $59.1M | ||
| Q3 24 | $95.5M | $80.5M | ||
| Q2 24 | $89.6M | $47.1M | ||
| Q1 24 | $85.1M | $43.8M |
净利润HIPOPBYI
| Q4 25 | $6.0M | — | ||
| Q3 25 | $98.1M | $8.8M | ||
| Q2 25 | $1.3M | $5.9M | ||
| Q1 25 | $-47.7M | $3.0M | ||
| Q4 24 | $44.2M | — | ||
| Q3 24 | $-8.5M | $20.3M | ||
| Q2 24 | $-40.5M | $-4.5M | ||
| Q1 24 | $-35.7M | $-4.8M |
毛利率HIPOPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HIPOPBYI
| Q4 25 | 5.6% | 22.7% | ||
| Q3 25 | 81.3% | 17.6% | ||
| Q2 25 | 3.4% | 12.7% | ||
| Q1 25 | -41.3% | 8.7% | ||
| Q4 24 | 46.3% | 22.6% | ||
| Q3 24 | -5.4% | 27.4% | ||
| Q2 24 | -40.7% | -4.6% | ||
| Q1 24 | -38.7% | -5.3% |
净利率HIPOPBYI
| Q4 25 | 5.0% | — | ||
| Q3 25 | 81.3% | 16.2% | ||
| Q2 25 | 1.1% | 11.2% | ||
| Q1 25 | -43.2% | 6.5% | ||
| Q4 24 | 43.4% | — | ||
| Q3 24 | -8.9% | 25.2% | ||
| Q2 24 | -45.2% | -9.6% | ||
| Q1 24 | -42.0% | -11.0% |
每股收益（稀释后）HIPOPBYI
| Q4 25 | $0.31 | $0.26 | ||
| Q3 25 | $3.77 | $0.17 | ||
| Q2 25 | $0.05 | $0.12 | ||
| Q1 25 | $-1.91 | $0.06 | ||
| Q4 24 | $1.81 | $0.40 | ||
| Q3 24 | $-0.34 | $0.41 | ||
| Q2 24 | $-1.64 | $-0.09 | ||
| Q1 24 | $-1.47 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $218.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $436.1M | $130.3M |
| 总资产 | $1.9B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HIPOPBYI
| Q4 25 | $218.3M | $97.5M | ||
| Q3 25 | $247.7M | $94.4M | ||
| Q2 25 | $198.9M | $96.0M | ||
| Q1 25 | $140.9M | $93.2M | ||
| Q4 24 | $197.6M | $101.0M | ||
| Q3 24 | $191.2M | $96.7M | ||
| Q2 24 | $175.9M | $96.8M | ||
| Q1 24 | $223.4M | $107.2M |
总债务HIPOPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HIPOPBYI
| Q4 25 | $436.1M | $130.3M | ||
| Q3 25 | $421.5M | $115.3M | ||
| Q2 25 | $332.5M | $104.7M | ||
| Q1 25 | $322.8M | $97.1M | ||
| Q4 24 | $362.1M | $92.1M | ||
| Q3 24 | $326.4M | $71.1M | ||
| Q2 24 | $322.6M | $48.5M | ||
| Q1 24 | $351.2M | $51.0M |
总资产HIPOPBYI
| Q4 25 | $1.9B | $216.3M | ||
| Q3 25 | $1.9B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.5B | $196.2M | ||
| Q4 24 | $1.5B | $213.3M | ||
| Q3 24 | $1.5B | $220.7M | ||
| Q2 24 | $1.5B | $205.0M | ||
| Q1 24 | $1.5B | $214.1M |
负债/权益比HIPOPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 7.6% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.53× | — |
| 过去12个月自由现金流最近4个季度 | $14.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HIPOPBYI
| Q4 25 | $9.2M | $14.4M | ||
| Q3 25 | $16.9M | $9.7M | ||
| Q2 25 | $24.7M | $14.1M | ||
| Q1 25 | $-35.6M | $3.6M | ||
| Q4 24 | $47.5M | $15.6M | ||
| Q3 24 | $46.8M | $11.0M | ||
| Q2 24 | $-10.6M | $1.0M | ||
| Q1 24 | $17.7M | $11.2M |
自由现金流HIPOPBYI
| Q4 25 | $9.1M | $14.4M | ||
| Q3 25 | $16.8M | $9.7M | ||
| Q2 25 | $24.6M | $14.1M | ||
| Q1 25 | $-35.7M | $3.6M | ||
| Q4 24 | $47.2M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $-10.7M | $1.0M | ||
| Q1 24 | $17.6M | — |
自由现金流率HIPOPBYI
| Q4 25 | 7.6% | 19.1% | ||
| Q3 25 | 13.9% | 17.7% | ||
| Q2 25 | 21.0% | 26.8% | ||
| Q1 25 | -32.4% | 7.7% | ||
| Q4 24 | 46.3% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | -11.9% | 2.1% | ||
| Q1 24 | 20.7% | — |
资本支出强度HIPOPBYI
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率HIPOPBYI
| Q4 25 | 1.53× | — | ||
| Q3 25 | 0.17× | 1.10× | ||
| Q2 25 | 19.00× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
